
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Meta‐analysis: Use of proton pump inhibitors and risk of gastric cancer in patients requiring gastric acid suppression
Daniele Piovani, Andreas G. Tsantes, Holger J. Schünemann, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 6, pp. 653-665
Open Access | Times Cited: 19
Daniele Piovani, Andreas G. Tsantes, Holger J. Schünemann, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 6, pp. 653-665
Open Access | Times Cited: 19
Showing 19 citing articles:
Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors
Naina Mohamed Pakkir Maideen
Chonnam Medical Journal (2023) Vol. 59, Iss. 2, pp. 115-115
Open Access | Times Cited: 34
Naina Mohamed Pakkir Maideen
Chonnam Medical Journal (2023) Vol. 59, Iss. 2, pp. 115-115
Open Access | Times Cited: 34
Timely Cessation of Proton Pump Inhibitors in Critically Ill Patients Impacts Morbidity and Mortality: A Propensity Score-Matched Cohort Study*
Lars Palmowski, Alexander von Busch, Matthias Unterberg, et al.
Critical Care Medicine (2024) Vol. 52, Iss. 2, pp. 190-199
Open Access | Times Cited: 6
Lars Palmowski, Alexander von Busch, Matthias Unterberg, et al.
Critical Care Medicine (2024) Vol. 52, Iss. 2, pp. 190-199
Open Access | Times Cited: 6
Recomendaciones de buena práctica clínica en la prescripción y deprescripción de inhibidores de la bomba de protones. Revisión por expertos de la AMG
Luis R. Valdovinos-García, A.S. Villar-Chávez, F.M. Huerta-Iga, et al.
Revista de Gastroenterología de México (2025)
Open Access
Luis R. Valdovinos-García, A.S. Villar-Chávez, F.M. Huerta-Iga, et al.
Revista de Gastroenterología de México (2025)
Open Access
Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population‐based cohort study
Eun Jeong Gong, Hye‐Kyung Jung, Bora Lee, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 7, pp. 668-677
Open Access | Times Cited: 9
Eun Jeong Gong, Hye‐Kyung Jung, Bora Lee, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 7, pp. 668-677
Open Access | Times Cited: 9
Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future
Amir Mari, Elisa Marabotto, Mentore Ribolsi, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 10, pp. 913-923
Closed Access | Times Cited: 8
Amir Mari, Elisa Marabotto, Mentore Ribolsi, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 10, pp. 913-923
Closed Access | Times Cited: 8
Magnetic-navigable silk fibroin microneedles for oral drug delivery: Ensuring long-lasting helicobacter pylori eradication and rapid hemostasis in the stomach
Haoyu Qiu, L GONG, Paul Slezak, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133584-133584
Closed Access | Times Cited: 2
Haoyu Qiu, L GONG, Paul Slezak, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133584-133584
Closed Access | Times Cited: 2
Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study
Jong Wook Kim, Hye‐Kyung Jung, Bora Lee, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 12, pp. 1699-1708
Closed Access | Times Cited: 7
Jong Wook Kim, Hye‐Kyung Jung, Bora Lee, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 12, pp. 1699-1708
Closed Access | Times Cited: 7
How safe are heartburn medications and who should use them?
Vincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 8, pp. 643-652
Closed Access | Times Cited: 6
Vincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 8, pp. 643-652
Closed Access | Times Cited: 6
Letter: Potassium‐competitive acid blockers may increase the risk of gastric cancer after Helicobacter pylori eradication a retrospective multicentre‐cohort analysis
Junya Arai, Yoku Hayakawa, Ryota Niikura, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 10, pp. 1196-1198
Open Access | Times Cited: 5
Junya Arai, Yoku Hayakawa, Ryota Niikura, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 10, pp. 1196-1198
Open Access | Times Cited: 5
Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease
Angela Tietto, Sofia Faggin, Carmelo Scarpignato, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024), pp. 1-16
Closed Access | Times Cited: 1
Angela Tietto, Sofia Faggin, Carmelo Scarpignato, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024), pp. 1-16
Closed Access | Times Cited: 1
Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies
Sharon Pan, Aaron P. Thrift, Ghida Akhdar, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 9, pp. 3732-3744
Closed Access | Times Cited: 3
Sharon Pan, Aaron P. Thrift, Ghida Akhdar, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 9, pp. 3732-3744
Closed Access | Times Cited: 3
Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic‐gland type: A retrospective, matched case–control study
Junnosuke Hayasaka, Shu Hoteya, Yutaka Takazawa, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 8, pp. 1580-1585
Closed Access
Junnosuke Hayasaka, Shu Hoteya, Yutaka Takazawa, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 8, pp. 1580-1585
Closed Access
A Proton Pump Inhibitor Independently Elevates Gastrin Levels as a Marker for Metachronous Gastric Cancer After Endoscopic Submucosal Dissection
Hajime Teshima, Hidehiko Takigawa, Takahiro Kotachi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6599-6599
Open Access
Hajime Teshima, Hidehiko Takigawa, Takahiro Kotachi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6599-6599
Open Access
Comment on “Risk of gastric cancer among long‑term proton pump inhibitor users: a population‑based cohort study”
Shih‐Wei Lai, Bing‐Fang Hwang, Chiu-Shong Liu, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 4, pp. 621-622
Closed Access
Shih‐Wei Lai, Bing‐Fang Hwang, Chiu-Shong Liu, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 4, pp. 621-622
Closed Access
Potential Chemopreventive Role of Proton Pump Inhibitors in Head and Neck Cancer: Insights from a Nested Case–Control Analysis of a National Health Screening Cohort
Joong Seob Lee, Soomin Jo, Ho Suk Kang, et al.
Journal of Personalized Medicine (2024) Vol. 15, Iss. 1, pp. 8-8
Open Access
Joong Seob Lee, Soomin Jo, Ho Suk Kang, et al.
Journal of Personalized Medicine (2024) Vol. 15, Iss. 1, pp. 8-8
Open Access
Editorial: PPIs and gastric cancer–Are we dealing with a carcinogen?
Peter Malfertheiner, Christian Schulz, Colin W. Howden
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 10, pp. 1099-1100
Open Access | Times Cited: 1
Peter Malfertheiner, Christian Schulz, Colin W. Howden
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 10, pp. 1099-1100
Open Access | Times Cited: 1
Letter: Potassium‐competitive acid blockers may increase the risk of gastric cancer after Helicobacter pylori eradication—a retrospective multicentre‐cohort analysis. Authors' reply
Daniele Piovani, Andreas G. Tsantes, Holger J. Schünemann, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 10, pp. 1199-1200
Open Access
Daniele Piovani, Andreas G. Tsantes, Holger J. Schünemann, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 10, pp. 1199-1200
Open Access
Do the benefits outweigh the risks? Potential dangers associated with long-term therapy of proton pump inhibitors
Izabela WOLANIN, Bartłomiej ZIELONKA, Barbara Dengler, et al.
Journal of Education Health and Sport (2023) Vol. 26, Iss. 1, pp. 63-80
Open Access
Izabela WOLANIN, Bartłomiej ZIELONKA, Barbara Dengler, et al.
Journal of Education Health and Sport (2023) Vol. 26, Iss. 1, pp. 63-80
Open Access
A Message from the Editors
Colin W. Howden, Rohit Loomba
Alimentary Pharmacology & Therapeutics (2023) Vol. 59, Iss. 1, pp. 4-5
Open Access
Colin W. Howden, Rohit Loomba
Alimentary Pharmacology & Therapeutics (2023) Vol. 59, Iss. 1, pp. 4-5
Open Access